Showing results (181-190 of 191) with videos related to
Sort By:
Pageof 20
Lung Cancer (Amsterdam, Netherlands)|March 15, 2025
Implications of EGFR expression on EGFR signaling dependency and adaptive immunity against EGFR-mutated lung adenocarcinomaMasahiro Torasawa, Tatsuya Yoshida, Kouya Shiraishi, et al.Lung Cancer (Amsterdam, Netherlands)|March 14, 2025
A phase 1b study of cofetuzumab pelidotin monotherapy in patients with PTK7-expressing recurrent non-small cell lung cancerByoung Chul Cho, Melissa Johnson, Jair Bar, et al.Cancer Science|September 28, 2022
High levels of AXL expression in untreated EGFR-mutated non-small cell lung cancer negatively impacts the use of osimertinibAkihiro Yoshimura, Tadaaki Yamada, Masakuni Serizawa, et al.Cancer Treatment and Research Communications|June 4, 2025
Plasma biomarkers for afatinib monotherapy in EGFR-mutated non-small cell lung cancer: Novel insights from companion genomics analysis of the EXTRA studyTomonori Makiguchi, Hisashi Tanaka, Kei Morikawa, et al.Therapeutic Advances in Medical Oncology|June 16, 2023
Prospective exosome-focused translational research for afatinib (EXTRA) study of patients with nonsmall cell lung cancer harboring EGFR mutation: an observational clinical studySaori Takata, Kei Morikawa, Hisashi Tanaka, et al.Scientific Reports|February 11, 2026
Efficacy and safety findings of the EXTRA study in older adult EGFR-mutant lung cancer patients receiving afatinib as first-line treatmentKei Morikawa, Saori Takata, Hisashi Tanaka, et al.Clinical Epigenetics|April 25, 2025
Plasma cell-free DNA methylation profile before afatinib treatment is associated with progression-free and overall survival of patients with epidermal growth factor receptor gene mutation-positive non-small cell lung cancerMao Fujimoto, Hiroyuki Yasuda, Eri Arai, et al.International Journal of Clinical Oncology|May 4, 2019
The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IVHiroaki Akamatsu, Kiichiro Ninomiya, Hirotsugu Kenmotsu, et al.Journal of Clinical Medicine|October 26, 2024
Intravenous Infusion of Autologous Mesenchymal Stem Cells Expanded in Auto Serum for Chronic Spinal Cord Injury Patients: A Case SeriesRyosuke Hirota, Masanori Sasaki, Satoshi Iyama, et al.JAMA Oncology|November 30, 2023
A Learning Program for Treatment Recommendations by Molecular Tumor Boards and Artificial IntelligenceKuniko Sunami, Yoichi Naito, Yusuke Saigusa, et al.Pageof 20